Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis
Piccolo R, Feres F, Valgimigli M et al.
KEYWORDS
clopidogrel; dual antiplatelet therapy; percutaneous coronary intervention
OBJECTIVES - The study sought to evaluate the presence of a clinically relevant rebound phenomenon after dual antiplatelet therapy (DAPT) discontinuation in randomized trials.